Determination of Residual Anticoagulatory Effects of Fondaparinux

Johann Wolfgang Goethe University Hospital

Status: Unknown

Conditions: Anticoagulant Prophylaxis/Therapy

Study type: Observational

Funder types: Other

Identifiers

NCT01101256

66/09

Details and patient eligibility

About

The purpose of this study is to determine residual anticoagulatory effects of a prophylactic or therapeutic fondaparinux treatment i.e. prior to surgery/intervention, after pause of therapy etc.

Enrollment: 110 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Fondaparinux therapy for at least 3 days

Exclusion criteria

• Age < 18 years
• Hemodialysis

Trial design

110 participants in 2 patient groups

Fondaparinux Prophylaxis group

Fondaparinux Therapy group